INJECTION SITE REACTIONS IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED SUBCUTANEOUS PEGCETACOPLAN MONOTHERAPY FOR UP TO 3 YEARS

EHA Library, Louise Arnold, 421423

CLINICAL CHARACTERISTICS AND OUTCOMES OF EGYPTIAN CHILDREN WITH FANCONI ANEMIA

EHA Library, Sara Makkeyah, 421424

THE EPIDEMIOLOGY OF APLASTIC ANEMIA IN AFRICA AND THE MIDDLE EAST: A SYSTEMATIC LITERATURE REVIEW

EHA Library, Shahrukh Hashmi, 421425

TREATMENT BURDEN OF PNH PATIENTS IN JAPAN: RESULTS OF THE QUALITATIVE INTERVIEW SURVEY STUDY

EHA Library, Yasutaka Ueda, 421426

IVIG AND DEXAMETHASONE IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH)

EHA Library, Shivani Joshi, 421427

DIAGNOSTIC PATHWAY AND CLINICAL MONITORING OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): RESULTS FROM A REAL-WORLD STUDY

EHA Library, Markus Radsak, 421428

EXPERIENCE OF PREGNANCY MANAGEMENT IN PATIENTS WITH APLASTIC ANEMIA AT DIFFERENT STAGES OF THE DISEASE

EHA Library, Anastasia Abramova, 421430

EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA: PATIENT-REPORTED OUTCOMES FROM THE PHASE 2 OPEN-LABEL EXTENSION STUDY

EHA Library, Ching Lum, 421431

UNDERSTANDING THE RELATIONSHIP BETWEEN HEMOGLOBIN, FATIGUE AND HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, Jens Panse, 421432

RECOMBINANT HUMAN THROMBOPOIETIN IMPROVES EARLY HEMATOLOGIC RESPONSE IN PATIENTS WITH NEWLY DIAGNOSED TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA

EHA Library, Ziwei Liu, 421433

EXPLORING STRATEGIES TO OPTIMISE OUTCOMES IN HEPATITIS-ASSOCIATED APLASTIC ANAEMIA PATIENTS FOLLOWING HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jia Li, 421434

POST-HEPATITIS APLASTIC ANEMIA,  EXPERIENCE OF SFAX HEAMATOLOGY DEPARTMENT

EHA Library, Nour Siala, 421435

SUCCESSFUL TREATMENT WITH ANTI-COMPLEMENT MOLECULE PEGCETACOPLAN IN LIVER TRANSPLANTATION FOR BUDD-CHIARI SYNDROME IN A PATIENT WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

EHA Library, Eduardo José Salido Fiérrez, 421436

PEGCETACOPLAN C3 INHIBITOR IMPROVE RESIDUAL ANEMIA IN PNH PATIENTS UNDER TREATMENT C5 INHIBITORS. EXPERIENCE TERTIARY HOSPITAL

EHA Library, Carmen Gonzalez Gonzalez, 421437

SURVIVAL ANALYSIS OF PATIENTS WITH FANCONI ANEMIA, FROM A SINGLE-CENTER CLINICAL STUDY IN CHINA

EHA Library, yiman gao, 421438

SAFETY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY OF HETROMBOPAG IN PEDIATRIC PATIENTS WITH APLASTIC ANEMIA: A PILOT STUDY

EHA Library, Lixian Chang, 421439

ANALYSIS OF REAL-WORLD DATA TO IDENTIFY PREDICTORS FOR EARLIER DIAGNOSIS OF APLASTIC ANEMIA

EHA Library, Phillip Scheinberg, 421440

THE RELATIONSHIP BETWEEN EARLY DIAGNOSIS/ TREATMENT OF SUSPECTED HLH (HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ) ON PATIENT SURVIVAL OUTCOMES: A CASE SERIES.

EHA Library, Marina Botros, 421441

TREATMENT LANDSCAPE AND CLINICAL UNMET NEEDS FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN CHINA: RESULTS FROM A REAL-WORLD STUDY

EHA Library, Bing Han, 421442

THE IMPACT OF ONLINE CME/CE ON MULTIDISCIPLINARY TEAM MEMBERS’ ABILITY TO CARE FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Michelle Worst, 421443

RABBIT VERSUS HORSE ATG IN SEVERE APLASTIC ANEMIA- SINGLE CENTER RETROSPECTIVE ANALYSIS

EHA Library, Cemaleddin Ozturk, 421444

LONG-TERM FOLLOW-UP RESULTS FROM CLINICAL STUDY OF HETROMBOPAG COMBINED WITH CYCLOSPORINE A IN THE TREATMENT OF CHILDREN WITH NON-SEVERE APLASTIC ANEMIA

EHA Library, Lixian Chang, 421445

PATIENT-REPORTED DISEASE BURDEN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN CHINA: RESULTS FROM A REAL-WORLD STUDY

EHA Library, Rong Fu, 421447

THE CLINICAL EFFICACY OF TPO RECEPTOR AGONISTS IN PROMOTING PLATELET RECOVERY AFTER INTENSIVE IMMUNOSUPPRESSION COMBINED WITH UMBILICAL CORD BLOOD TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA.

EHA Library, Zhou fang, 421448

HAEMATOLOGICAL ABNORMALITIES IN PATIENTS WITH ANOREXIA NERVOSA AND OTHER SEVERE EATING DISORDERS IN WHILST IN-PATIENTS AT A SPECIALIST TREATMENT UNIT

EHA Library, Miriam Portela McKean, 421449

NOVEL DESIGNS FOR ENHANCING CAR-T THERAPY AGAINST MULTIPLE MYELOMA TARGETING BCMA

EHA Library, Jorge Illarramendi Esteban, 421450

DYNAMIC CHANGES IN GAMMA DELTA T CELLS AND BONE RESORPTION MARKERS AFTER ZOLEDRONIC ACID IN MULTIPLE MYELOMA: A PROSPECTIVE STUDY

EHA Library, Chao-Hung Wei, 421451

SKY92 MOLECULAR PROFILING IN COMBINATION WITH MRD BY NGS TO IDENTIFY HIGH-RISK MULTIPLE MYELOMA PATIENTS IN IRELAND (MM-PIRE)

EHA Library, Roisin McAvera, 421452

SERUM METABOLIC CHANGES ASSOCIATED WITH THE PROGRESSION FROM MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE TO SMOLDERING MULTIPLE MYELOMA

EHA Library, Inés Dolz Sales, 421453

MUTATIONAL LANDSCAPE BY NGS IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA. EXPERIENCE OF HEMATOLOGICAL DIAGNOSTIC GROUP OF ALICANTE

EHA Library, Rocio Gonzalez-Martinez, 421454

THE SIDE-EFFECT BURDEN OF TREATMENTS IN MULTIPLE MYELOMA IN A REAL-WORLD POPULATION: EXPLORING THE ONGOING IMPACT OF SIDE-EFFECTS ON THE DAILY LIVES OF PATIENTS

EHA Library, Lauren Kelly, 421455

" BACTERIA INVOLVED IN THE METABOLISM OF SHORT-CHAIN FATTY ACIDS (SCFAS) MAY INFLUENCE THE DEVELOPMENT OF MULTIPLE MYELOMA".

EHA Library, Michał Bator, 421456

NCX1/CA2+ PROMOTES AUTOPHAGY AND DECREASES BORTEZOMIB ACTIVITY IN MULTIPLE MYELOMA THROUGH NON-CANONICAL NFΚB SIGNALING PATHWAY

EHA Library, Tingting Li, 421457

A NOVEL AND PERSONALIZED PRECISION-PDX MODEL FOR ELIMINATION OF MINIMAL RESIDUAL DISEASE( MRD ) FOR PATIENTS WITH MULTIPLE MYELOMA ( MM ) BY MAGNETIC-INDUCED NK CELLS（MAGIC-NK）

EHA Library, Jialu Zhang, 421458

T LYMPHOCYTE SUBGROUPS IN THE BONE MARROW MICRO ENVIRONMENT IN MULTIPLE MYELOMA: TUMOR-DIRECTED T CELLS PLAY A ROLE IN FIGHTING CANCER.

EHA Library, Ali Unal, 421459

PIM2 KINASE REGULATES TIGIT EXPRESSION AND FUNCTION IN NK CELLS FROM MULTIPLE MYELOMA PATIENTS

EHA Library, Zhaoyun Liu, 421460

THE MECHANISM OF STAT3 INHIBITORS INDUCING DNA DAMAGE IN MULTIPLE MYELOMA CELLS AND ENHANCING THE ANTI-TUMOR EFFECTS OF NK CELLS

EHA Library, Zhaoyun Liu, 421461

DISSECTING THE CONTRIBUTION OF CIRCULATING PROTEINS TO MULTIPLE MYELOMA RISK: A MENDELIAN RANDOMIZATION STUDY

EHA Library, Lucy Goudswaard, 421462

NOVEL ANTIGENS LMA AND KMA ARE EXPRESSED ON BONE MARROW PLASMA CELLS FROM PATIENTS WITH AL AMYLOIDOSIS BUT THEY ARE NOT DETECTED ON NORMAL PLASMA CELLS

EHA Library, Aintzane Zabaleta, 421463

OPTIMIZING PRIMARY PATIENT-DERIVED TOTAL MARROW MULTIPLE MYELOMA CELL CULTURE

EHA Library, Ariene Cabantog, 421464

PAEONIFLORIN INHIBITS OSTEOCLAST TRANSFORMATION THROUGH THE ERK1-RANKL PATHWAY

EHA Library, xing cui, 421465

BORTEZOMIB INTERFERES WITH PARKIN-MEDIATED MITOCHONDRIAL AUTOPHAGY LEADING TO NEUROTOXICITY

EHA Library, Xing Cui, 421466

ALOX12 AND THE LIPID LANDSCAPE: IMPLICATIONS FOR THERAPY RESPONSE AND IMMUNOTHERAPY RESISTANCE IN MULTIPLE MYELOMA

EHA Library, Enrico La Spina, 421468

INCREASED LEVELS OF FIBRINOGEN AND TISSUE FACTOR ARE BIOMARKERS OF THROMBOSIS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Tijana Subotički, 421469

UNLOCKING MULTIPLE MYELOMA INSIGHTS: ESTABLISHMENT OF A XENOGRAFT MODEL ON THE CHICK EMBRYO CHORIOALLANTOIC MEMBRANE FOR TUMOUR GROWTH AND DRUG TESTING STUDIES

EHA Library, Izabela Cymer, 421470

THE RISING UNMET NEED FOR MULTIPLE MYELOMA PATIENTS AFTER FIRST-LINE TREATMENT WITH DRD: AN EPIDEMIOLOGICAL ESTIMATE IN ITALY BETWEEN 2024-2028

EHA Library, Mario Boccadoro, 421471

PCDH10 INHIBITS PROLIFERATION, MIGRATION AND ANGIOGENESIS OF MULTIPLE MYELOMA CELLS VIA PI3K/AKT

EHA Library, Chensi Zeng, 421472

CLUSTERS OF IMMUNE CHECKPOINTS IN MULTIPLE MYELOMA UNVEILS PATIENTS’ STRATIFICATION AND SINERGISTIC IMMUNOTHERAPY

EHA Library, Laura Martinez-Verbo, 421473

THE ROLE OF PROLIFERATING STEM-LIKE PLASMA CELLS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: INSIGHTS FROM SINGLE-CELL RNA SEQUENCING AND PROTEOMIC ANALYSIS

EHA Library, Jiadai Xu, 421474

INCIDENCE AND INCIDENCE TRENDS OF MULTIPLE MYELOMA AND PLASMA CELL NEOPLASMS IN NORTHEAST SPAIN, 1994-2020

EHA Library, rafael marcos-gragera, 421475

UNLOCKING MULTIPLE MYELOMA INSIGHTS: ESTABLISHMENT OF A XENOGRAFT MODEL ON THE CHICK EMBRYO CHORIOALLANTOIC MEMBRANE FOR TUMOUR GROWTH AND DRUG TESTING STUDIES

EHA Library, Izabela Cymer, 421476

IMPACT OF OPIOID USE ON LONG-TERM SURVIVAL IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Marta Hidalgo, 421477

THE ROLE OF GALECTIN-3 IN MULTIPLE MYELOMA WITH KIDNEY DAMAGE

EHA Library, Zhanna Kozich, 421478

TRIPLE AND PENTA-REFRACTORY MULTIPLE MYELOMA IN IRELAND; A NATIONAL STUDY OF TREATMENT REGIMEN UTILIZATION AND RESISTANCE PATTERNS.

EHA Library, Jimmy William, 421480

ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH SYSTEMIC AL AMYLOIDOSIS

EHA Library, Viktoria Khyshova, 421481

OUTCOME OF OCTOGENARIAN PATIENTS WITH MULTIPLE MYELOMA TREATED OUTSIDE CLINICAL STUDIES, FOCUSING ON TOLERABILITY AND EFFICACY OF TREATMENT

EHA Library, Dana Amsterdam, 421482

RESULTS FROM THE CHINA COHORT OF THE PHASE 1/2 MAJESTEC-1 STUDY OF TECLISTAMAB (TEC) TREATMENT IN PATIENTS (PTS) WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Zhen Cai, 421483

SELINEXOR COMBINED BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE(EMD)

EHA Library, Yuping Zhong, 421484

MAINTENANCE THERAPY WITH IXAZOMIB VERSUS LENALIDOMIDE IN NEWLY-DIAGNOSED MULTIPLE MYELOMA: A REAL-WORLD STUDY

EHA Library, Xuzhao Zhang, 421485

DELETION OF 1P32 IS AN ADVERSE PROGNOSTIC FACTOR FOR MULTIPLE MYELOMA PATIENTS :A SINGLE-CENTER STUDY IN CHINA

EHA Library, Juan Li, 421486

OUTCOME OF MULTIPLE MYELOMA WITH ASSOCIATED BONE INDEPENDENT EXTRAMEDULLARY DISEASE (EMD) - A UK SINGLE CENTER EXPERIENCE

EHA Library, Ke Xu, 421487

VASCULAR ENDOTHELIAL GROWTH FACTOR IS NOT THE BEST ASSESSMENT OF EFFICACY IN POEMS SYNDROME

EHA Library, Juan Li, 421488

PRIMARY RESULTS OF A PHASE 1/2 STUDY OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN JAPANESE PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Shinsuke Iida, 421489

IMMAGINE-3: A PHASE 3, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ANITOCABTAGENE AUTOLEUCEL (ANITO-CEL) WITH STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Thomas Martin, 421490

LOW-DOSE APIXABAN AS PRIMARY THROMBOPROPHYLAXIS IN PATIENTS WITH MULTIPLE MYELOMA ON IMMUNOMODULATORY DRUGS

EHA Library, Carlos Aguilar, 421492

TREATMENT OF NEWLY DIAGNOSED FRAIL MULTIPLE MYELOMA PATIENTS WITH LENALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE

EHA Library, Maher Salamoon, 421493

HIGH BONE MARROW PLASMA CELL PERCENTAGE MAY IMPROVE THE R-ISS RISK STRATIFICATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A SINGLE-CENTRE REAL-WORLD EXPERIENCE IN CHINA

EHA Library, JIE SHI, 421494

REAL-WORLD EFFECTIVENESS AND SAFETY OF ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN CHINESE PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA: A SINGLE-ARM PROSPECTIVE STUDY

EHA Library, Weili Zhao, 421495

SPINAL -CORD COMPRESSION IN MULTIPLE MYELOMA . ALGERIAN MULTICENTER RETROSPECTIVE STUDY

EHA Library, Meriem benhalilou, 421496

EFFICACY AND SAFETY OF DARATUMUMAB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MOROCCAN SINGLE-CENTER REAL-LIFE STUDY.

EHA Library, Yasmine Moutmir, 421497

DYNAMIC INCREASE IN SERUM CHOLESTEROL LEVELS CONTRIBUTES TO LONG-TERM REMISSION AFTER AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Yuan Chen, 421498

REAL-WORLD STUDY OF CARFILZOMIB-BASED CHEMOTHERAPY REGIMEN FOR THE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Hui Li, 421499

CLINICAL STUDY OF ORAL REGIMEN FOR ELDERLY REFRACTORY MULTIPLE MYELOMA

EHA Library, Yuping Zhong, 421500

GLOMERULAR PROTEINURIA IN PATIENTS WITH TRIPLE CLASS REFRACTORY MULTIPLE MYELOMA DURING BELANTAMAB MAFODOTIN TREATMENT: A SINGLE CENTER EXPERIENCE

EHA Library, Laura Pavan, 421502

A SINGLE-CENTER STUDY ON THE USE OF THALIDOMIDE MAINTENANCE THERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Lun-Wei Chiou, 421503

THE DIAGNOSTIC ENIGMA OF POEMS SYNDROME CASE SERIES FROM A SINGLE CENTRE

EHA Library, Bhavani Mandava, 421504

EXPRESSION AND PREDICTIVE VALUE OF CD24 ANTIGEN IN MULTIPLE MYELOMA PATIENTS

EHA Library, Mengru Liu, 421505

COMBINATION OF DARATUMUMAB AND BENDAMUSTINE IS AN EFFECTIVE TREATMENT FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Hong Cen, 421506

LIMITED EFFICACY OF DARATUMUMAB IN HIGH RISK RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS: A SINGLE CENTRE REAL-LIFE EXPERIENCE

EHA Library, Sonia Morè, 421507

AN ANALYSIS OF CLONAL ISOTYPE SWITCHING (CIS) FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS: A RETROS STUDY

EHA Library, LIJING SHEN, 421508

CLINICAL STUDY ON PROPHYLACTIC USE OF TPO-RA TO PROMOTE MEGAKARYOCYTE RECONSTRUCTION IN PATIENTS WITH MM AFTER ASCT

EHA Library, Juan Li, 421509

REAL WORLD UTILISATION OF MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA ACROSS EUROPE: A FEASIBILITY ASSESSMENT FOR THE MERMAID STUDY

EHA Library, Bruno Paiva, 421510

REAL-WORLD EVIDENCE EVALUATING TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC LITERATURE REVIEW

EHA Library, Benjamin A Derman, 421511

EFFICACY OF MELFLUFEN IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND MUTATED OR DELETED TP53

EHA Library, Klara ACS, 421512

RETROSPECTIVE OBSERVATIONAL STUDY OF THE TREATMENT OF WALDENSTRÖM'S MACROGLOBULINEMIA WITH IBRUTINIB IN ROUTINE CLINICAL PRACTICE IN SPAIN

EHA Library, Eva Rubio Azpeitia, 421513

EARLY UNITED STATES (US) USERS OF TALQUETAMAB FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): A REAL-WORLD ANALYSIS OF PATIENT CHARACTERISTICS AND TREATMENT HISTORY

EHA Library, Hoa Le, 421515

CPD-DARA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: PRELIMINARY RESULTS FROM THE CTRIAL-IE 19-17 STUDY SHOWS EARLY EVIDENCE OF EFFICACY

EHA Library, Janusz Krawczyk, 421516

ENHANCING BENEFIT-RISK ASSESSMENT IN MULTIPLE MYELOMA USING MULTI-STATE MODELING IN THE RANDOMIZED PHASE 3 EMN02/HO95 TRIAL.

EHA Library, Anna Smit, 421517

TRIAL IN PROGRESS: ALUMMINATE RRMM – A RANDOMIZED PHASE 3 STUDY OF ALNUCTAMAB, A BCMA-TARGETING T-CELL ENGAGER, VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY (RR) MULTIPLE MYELOMA (MM)

EHA Library, Noffar Bar, 421518

PLASMA CELL LEUKEMIA, REAL WORLD EXPERIENCE IN A MULTICENTER MEXICAN COHORT

EHA Library, Paulina Ramirez, 421520

POMA-BASED THERAPY AFTER DARATUMUMAB: A SINGLE CENTER EXPERIENCE

EHA Library, Martina Lorenzon, 421521

EFFICACY AND SAFETY OF CARFILZOMIB PLUS POMALIDOMIDE AND DEXAMETHASONE AS SALVAGE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN CHINA

EHA Library, Wenbin Qian, 421522

EFFICACY AND SAFETY OF THE CARFILZOMIB COMBINATION REGIMEN FOR PATIENTS WITH MULTIPLE MYELOMA IN CHINA: A REAL-WORLD ANALYSIS

EHA Library, Zhong-jun Xia, 421523

EFFICACY AND SAFETY OF CARFILZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE FOR THE TREATMENT OF POEMS SYNDROME

EHA Library, Hao Li, 421524

PROGNOSTIC VALUE OF HEMOGLOBINE TO RED CELL DISTRIBUTION WIDTH RATIO FOR PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Nikol Marošević, 421525

CHANGE OF ESTIMATED GLOMERULAR FILTRATION RATE ASSOCIATES WITH ALL-CAUSE MORTALITY IN MULTIPLE MYELOMA

EHA Library, Xiang Liu, 421527

DARATUMUMAB IS ONE OF THE MAIN DRIVERS OF OUTCOME IMPROVEMENT IN PATIENTS WITH AL AMYLOIDOSIS

EHA Library, Elena Alejo, 421528

DARATUMUMAB AND BORTEZOMIB AS MAINTENANCE IN NEWLY DIAGNOSED MYELOMA MULTIPLE IN NOT ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION REAL LIFE PATIENTS.

EHA Library, María del Carmen Gilabert Gutiérrez, 421529

MONOCLONAL GAMMOPATHY OF CLINICAL SIGNIFICANCE: INSIGHTS FROM A TERTIARY REFERRAL CENTER EXPERIENCE IN MEXICO

EHA Library, Sergio Rodriguez-Rodriguez, 421530

SECONDARY HYPOGAMMAGLOBULINEMIA ASSOCIATED WITH ANTI-CD38. EVALUATION OF CASES IN A HOSPITAL IN MADRID.

EHA Library, Gonzalo Benzo Callejo, 421531